Cargando…

Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen

Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Eissa, Shimaa, Alhadrami, Hani A., Al-Mozaini, Maha, Hassan, Ahmed M., Zourob, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153846/
https://www.ncbi.nlm.nih.gov/pubmed/34041585
http://dx.doi.org/10.1007/s00604-021-04867-1
_version_ 1783698885789614080
author Eissa, Shimaa
Alhadrami, Hani A.
Al-Mozaini, Maha
Hassan, Ahmed M.
Zourob, Mohammed
author_facet Eissa, Shimaa
Alhadrami, Hani A.
Al-Mozaini, Maha
Hassan, Ahmed M.
Zourob, Mohammed
author_sort Eissa, Shimaa
collection PubMed
description Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and manage the outbreak. Here, a label-free square wave voltammetry-based biosensing platform for the detection of SARS-CoV-2 in nasopharyngeal samples is reported. The sensor was constructed on screen-printed carbon electrodes coated with gold nanoparticles. The electrodes were functionalized using 11-mercaptoundecanoic acid (MUA) which was used for the immobilization of an antibody against SARS-CoV-2 nucleocapsid protein (N protein). The binding of the immunosensor with the N protein caused a change in the electrochemical signal. The detection was realised by measuring the change in reduction peak current of a redox couple using square wave voltammetry at 0.04 V versus Ag ref. electrode on the immunosensor upon binding with the N protein. The electrochemical immunosensor showed high sensitivity with a linear range from 1.0 pg.mL(−1) to 100 ng.mL(−1) and a limit of detection of 0.4 pg.mL(−1) for the N protein in PBS buffer pH 7.4. Moreover, the immunosensor did not exhibit significant response with other viruses such as HCoV, MERS-CoV, Flu A and Flu B, indicating the high selectivity of the sensor for SARS-CoV-2. However, cross reactivity of the biosensor with SARS-CoV is indicated, which gives ability of the sensor to detect both SARS-CoV and SARS-CoV-2. The biosensor was successfully applied to detect the SARS-CoV-2 virus in clinical samples showing good correlation between the biosensor response and the RT-PCR cycle threshold values. We believe that the capability of miniaturization, low-cost and fast response of the proposed label-free electrochemical immunosensor will facilitate the point-of-care diagnosis of COVID 19 and help prevent further spread of infection.
format Online
Article
Text
id pubmed-8153846
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-81538462021-05-28 Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen Eissa, Shimaa Alhadrami, Hani A. Al-Mozaini, Maha Hassan, Ahmed M. Zourob, Mohammed Mikrochim Acta Original Paper Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and manage the outbreak. Here, a label-free square wave voltammetry-based biosensing platform for the detection of SARS-CoV-2 in nasopharyngeal samples is reported. The sensor was constructed on screen-printed carbon electrodes coated with gold nanoparticles. The electrodes were functionalized using 11-mercaptoundecanoic acid (MUA) which was used for the immobilization of an antibody against SARS-CoV-2 nucleocapsid protein (N protein). The binding of the immunosensor with the N protein caused a change in the electrochemical signal. The detection was realised by measuring the change in reduction peak current of a redox couple using square wave voltammetry at 0.04 V versus Ag ref. electrode on the immunosensor upon binding with the N protein. The electrochemical immunosensor showed high sensitivity with a linear range from 1.0 pg.mL(−1) to 100 ng.mL(−1) and a limit of detection of 0.4 pg.mL(−1) for the N protein in PBS buffer pH 7.4. Moreover, the immunosensor did not exhibit significant response with other viruses such as HCoV, MERS-CoV, Flu A and Flu B, indicating the high selectivity of the sensor for SARS-CoV-2. However, cross reactivity of the biosensor with SARS-CoV is indicated, which gives ability of the sensor to detect both SARS-CoV and SARS-CoV-2. The biosensor was successfully applied to detect the SARS-CoV-2 virus in clinical samples showing good correlation between the biosensor response and the RT-PCR cycle threshold values. We believe that the capability of miniaturization, low-cost and fast response of the proposed label-free electrochemical immunosensor will facilitate the point-of-care diagnosis of COVID 19 and help prevent further spread of infection. Springer Vienna 2021-05-26 2021 /pmc/articles/PMC8153846/ /pubmed/34041585 http://dx.doi.org/10.1007/s00604-021-04867-1 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Eissa, Shimaa
Alhadrami, Hani A.
Al-Mozaini, Maha
Hassan, Ahmed M.
Zourob, Mohammed
Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
title Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
title_full Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
title_fullStr Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
title_full_unstemmed Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
title_short Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen
title_sort voltammetric-based immunosensor for the detection of sars-cov-2 nucleocapsid antigen
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153846/
https://www.ncbi.nlm.nih.gov/pubmed/34041585
http://dx.doi.org/10.1007/s00604-021-04867-1
work_keys_str_mv AT eissashimaa voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen
AT alhadramihania voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen
AT almozainimaha voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen
AT hassanahmedm voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen
AT zourobmohammed voltammetricbasedimmunosensorforthedetectionofsarscov2nucleocapsidantigen